Managers / Q3 2022 · view latest →
JET CAPITAL INVESTORS L P
CIK 0001278235 · 515 MADISON AVENUE, SUITE 22A, NEW YORK, NY, 10022 · 2123722510
Summary
Jet Capital Investors L P reported $480M in U.S.-listed holdings across 15 positions for Q3 2022.
Its largest position, Vmware, represents 8.9% of the portfolio.
Compared with Q2 2022, the fund opened 5 new positions and exited 11.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Other · 61.5% · $295M
- Common Stock · 24.8% · $119M
- ETP · 10.7% · $51M
- Tracking Stk · 1.9% · $9M
- Right · 1.2% · $6M
Quarter-over-Quarter Changes full breakdown →
vs Q2 2022 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| TWITTER INC | NEW | +500.0K | 500.0K | +$22M | $22M |
| KNOWBE4 INC | NEW | +283.7K | 283.7K | +$6M | $6M |
| ACTIVISION BLIZZARD INC | NEW | +75.0K | 75.0K | +$6M | $6M |
| CHANGE HEALTHCARE INC | NEW | +155.0K | 155.0K | +$4M | $4M |
| BHVNBIOHAVEN LTD | NEW | +115.0K | 115.0K | +$725,000 | $725,000 |
| BIOHAVEN PHARMACTL HLDG CO L | ADDED | +1.62M | 1.88M | +$247M | $285M |
| VMWARE INC | ADDED | +415.0K | 625.0K | +$43M | $67M |
| GSK PLC | SOLD OUT | −1.14M | 0 | −$49M | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2022
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | VMWARE INC | CL A COM | 8.87% | $43M | 400.0K |
| 2 | BIOHAVEN PHARMACTL HLDG CO L | COM | 5.37% | $26M | 170.0K |
| 3 | TWITTER INC | COM | 4.57% | $22M | 500.0K |
| 4 | TSEMTOWER SEMICONDUCTOR LTDhistory → | SHS NEW | 3.89% | $19M | 425.0K |
| 5 | LIBERTY MEDIA CORP DEL | COM C BRAVES GRP | 1.92% | $9M | 335.0K |
| 6 | ACTIVISION BLIZZARD INC | COM | 1.16% | $6M | 75.0K |
| 7 | BMY-R | RIGHT 99/99/9999 | 1.15% | $6M | 2.76M |
| 8 | ISTAR INC | COM | 0.92% | $4M | 475.0K |
| 9 | CHANGE HEALTHCARE INC | COM | 0.89% | $4M | 155.0K |
| 10 | BLACK KNIGHT INC | COM | 0.27% | $1M | 20.0K |
| 11 | BHVNBIOHAVEN LTD | COM | 0.15% | $725,000 | 115.0K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q3 2024 | $0 | 1 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $0 | 1 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $0 | 1 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $51M | 27 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $67M | 18 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $519M | 27 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $296M | 17 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $263M | 16 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $480M | 15 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $308M | 22 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $638M | 37 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $378M | 28 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $586M | 33 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $528M | 28 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $570M | 37 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $398M | 25 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020REVEALED | $440M | 29 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $485M | 31 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $214M | 20 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $525M | 33 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $473M | 26 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $507M | 24 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $490M | 21 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.